Ethical Issues in the Treatment of Late-Stage Alzheimer’s Disease

There is hope that the continuing efforts of researchers will yield a disease-modifying drug for Alzheimer’s disease. Such a drug is likely to be capable of halting, or significantly slowing, the underlying pathological processes driving cognitive decline; however, it is unlikely to be capable of re...

Descripción completa

Detalles Bibliográficos
Autores principales: Watt, Andrew D., Jenkins, Nicole L., McColl, Gawain, Collins, Steven, Desmond, Patricia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Ethics Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484269/
https://www.ncbi.nlm.nih.gov/pubmed/30475773
http://dx.doi.org/10.3233/JAD-180865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484269/
https://www.ncbi.nlm.nih.gov/pubmed/30475773
http://dx.doi.org/10.3233/JAD-180865

Ejemplares similares